APPLICATIONS PUBLISHED 19 FEBRUARY 2003
Published: 1-Aug-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna.
T +43 1521 260 F +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna.
T +43 1521 260 F +43 1 52126 4492
Preparation of injectable suspension having improved injectability
Alkermes Controlled Therapeutics 1283699*
Sustained release pharmaceutical compsns for parenteral administration of hydrophilic compounds
Italfarmaco 1283700*
A coating compsn for facilitating controlled release
Ranbaxy Laboratories 1283701*
Medical dressing assembly and associated method of using the same
David, James Johnson 1283702*
Rapidly disintegrating tablet and process for the manufacture thereof
Hanmi Pharm 1283703*
Pharmaceutical compsns for transdermal administration of anti-inflammatory agents
Sanofi-Synthelabo 1283704*
Transdermal therapeutical system with a reduced tendency of the active substance to crystallise
LTS Lohmann Therapie-Systeme 1283705*
Dosage of transdermal delivery systems
Euroceltique 1283706*
Polymerisable compsns and methods of use
Provasis Therapeutics 1283707*
Use of bisguanidine derivatives for making a medicine having a wound healing effect
Centre National de la Recherche Scientifique 1283708*
Peptide deformylase inhibitors
SmithKline Beecham 1283709*
Use of a celecoxib compsn for fast pain relief
Pharmacia 1283710*
peptide deformylase inhibitors
SmithKline Beecham 1283711*
Combination chemotherapy
Anormed 1283712*
Combined cartilage and plant extract compsns
Ferosan 1283713*
Use of Lactobacillus casei in immunostimulatory peptides
Compagnie Gervais-Danone 1283714*
Modulation of alpha-6 integrin-mediated responses
Histatek LLC 1283715*
Vaccine comprising a tick cement protein
Evolutec 1283716*
Recombinant fusonacterium necrophorum leukotoxin vaccine and preparation thereof
Kansas State University Research Foundation 1283717*
Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant avipoxvirus vaccine
Merial 1283718*
Apoptotic agents
Barth, Stefan; Engert, Andreas; Stoecker, Michael 1283719*
Recombinant or purified polyclonal antibodies for treating allergy
Symphogen 1283720*
Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
SmithKline Beecham Corp; SmithKline Beecham PLC 1283721*
Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for the treatment of T-cell lymphoma
Idec Pharmaceuticals 1283722*
Combination therapy using COX-2 selective inhibitor and thromboxane inhibitor and compsns therefor
Merck Frosst Canada 1283723*
Systems and methods for topical treatment with nitric oxide
Nitric Oxide Solutions 1283724*
Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof
Lee, Sang Deuk 1283725*
Dendritic cells loaded with toxic substances
Toximed 1283726*
Compsns and methods for inducing activation of dendritic cells
Supratek Pharma 1283727*
Contrast agents
Amersham Health 1283728*
TC and RE carbonyl complexes for pertechnetate and perrhenate
Mallinckrodt 1283729*
Jaw transplant consisting of natural bone material
Tutogen Medical 1283730*
Medicament container with same side airflow inlet and outlet and method of use
Innovative Devices 1283731*
Photoreceptor system for melatonin regulation and phototherapy
Thomas Jefferson University 1283733*
Method for the improvement of islet signalling in diabetes mellitus and for its prevention
Probiodrug 1283735*
